Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial biofilm matrix and iron-dependent signaling pathway constitute a multi-component system essential for the development and structural integrity of bacterial biofilms. The matrix is an organized scaffold of extracellular polymeric substances (EPS), including polysaccharides, proteins, and extracellular DNA, which shields bacteria from environmental stressors and host defenses (Flemming & Wingender, 2010). Iron acts as a pivotal regulatory signal in this process; for instance, in Pseudomonas aeruginosa, iron levels dictate the transition between motile and biofilm-associated states through specialized signaling systems (Banin et al., 2005). Targeting this system involves disrupting iron acquisition using chelators like deferoxamine or iron mimetics like gallium, which starve the bacteria or poison iron-dependent metabolic pathways (Kaneko et al., 2007). Additionally, therapeutic agents may target the physical matrix itself, using enzymes like dornase alfa to degrade eDNA or dispersin B to break down polysaccharides, thereby destabilizing the biofilm and increasing its susceptibility to conventional antibiotics (Musk et al., 2005). This dual approach of targeting both the regulatory signals and the physical architecture is a prominent strategy in treating chronic, recalcitrant infections such as those found in cystic fibrosis or on medical implants.
Disruption of iron-dependent signaling and metabolism via sequestration or mimetic substitution, and enzymatic degradation of the extracellular polymeric matrix to facilitate antimicrobial penetration.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial biofilm matrix and iron-dependent signaling pathway.